DioGenix
Amarantus Acquires DioGenix for up to $10.9M
DioGenix and its MSPrecise NGS test for multiple sclerosis will be merged into Amarantus as a foundational asset of a growing neuro-diagnostic business.
DioGenix and its MSPrecise NGS test for multiple sclerosis will be merged into Amarantus as a foundational asset of a growing neuro-diagnostic business.